Ga-68-DOTATATE Uptake in Pancreatic Metastasis of Renal Cell Carcinoma Mimicking Pancreatic Neuroendocrine Tumor

Creative Commons License

Soydal Ç., Nak D., Araz M., Demirkazık A., Küçük N. Ö.

CLINICAL NUCLEAR MEDICINE, cilt.44, sa.10, ss.795-796, 2019 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Editöre Mektup
  • Cilt numarası: 44 Sayı: 10
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1097/rlu.0000000000002718
  • Dergi Adı: CLINICAL NUCLEAR MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.795-796
  • Anahtar Kelimeler: Ga-68-DOTATATE, PET, renal cell carcinoma, PET/CT, MANAGEMENT
  • Ankara Üniversitesi Adresli: Evet

Özet

A 61-year-old man, with a history of prior clear cell renal cell carcinoma in remission, was referred to Ga-68-DOTATATE PET/CT for the further evaluation of pancreatic tail mass. Ga-68-DOTATATE PET/CT showed pathologically intense uptake on the pancreatic mass; subsequent biopsy of the pancreatic mass confirmed the diagnosis of clear cell renal cell carcinoma metastasis. Ga-68-DOTATATE uptake is not specific for neuroendocrine tumors. In the presence of prior malignancy, it should be kept in mind that malignancies apart from neuroendocrine tumors express somatostatin receptors, and they can show Ga-68-DOTATATE uptake.